Ruben Osnabrugge, MD PhD, joined LSP in 2021 as an associate and is part of the health economic funds. He focuses on investment opportunities in private companies in Med Tech, Diagnostics and Digital Health. 

 

Prior to joining LSP, Ruben led the Value-Based Care strategy for Philips. He also supported strategic deep dives and due diligence for Philips’s investments. Moreover, he represented the company at Medtech Europe and led a World Economic Forum project with Intermountain Healthcare and Novartis.

 

Before, Ruben underwent surgical training in cardio-thoracic surgery with a special interest in interventional cardiology at Erasmus University Medical Center. As part of this training, he also performed general and vascular surgery and worked at the intensive care. 

 

Ruben is a recognized expert in cost-effectiveness and health outcomes research, especially in coronary revascularization and structural heart interventions. He received a Fulbright Scholarship which he spent at the Mid-America Heart Institute in Kansas City to work on pivotal cardiovascular clinical trials. He has (co-)authored >40 articles in top peer-reviewed medical journals including JAMA, European Heart Journal, and the Journal of the American College of Cardiology, two chapters in the ESC Textbook of Cardiovascular Medicine and a European clinical guideline. Moreover, he was editorial board member at Eurointervention Journal and faculty at leading interventional cardiology and surgical societies EuroPCR and EACTS, from which he also received a young investigator award.

 

Ruben holds MD and PhD degrees from Erasmus Medical School in Rotterdam, a MSc in clinical research from NIHES and the Harvard School of Public Health, and a BSc in health economics from Erasmus School of Economics. Ruben lives in Amsterdam, in his spare time he is an avid cyclist and enjoys traveling, good food and photography.